fulvestrant has been researched along with 2-hydroxyestradiol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubey, RK; Fingerle, J; Gillespie, DG; Jackson, EK; Korzekwa, KR; Rosselli, M; Zacharia, LC | 1 |
| Dubey, RK; Imthurn, B; Jackson, EK; Keller, PJ; Rosselli, M | 1 |
| Baylis, C; Dubey, RK; Gillespie, DG; Jackson, EK; Xiao, S | 1 |
| Chang, LW; Chang, YC; Ho, CC; Lin, P; Tsai, MH | 1 |
| Dubey, RK; Imesch, P; Leeners, B; Samartzis, EP; Twiehaus, A | 1 |
| Buñay, J; Castro, A; Florez, M; Molina, C; Moreno, RD; Orihuela, PA; Parada-Bustamante, A; Valencia, C | 1 |
6 other study(ies) available for fulvestrant and 2-hydroxyestradiol
| Article | Year |
|---|---|
Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms.
Topics: 2-Methoxyestradiol; Animals; Aorta; Aorta, Thoracic; Catechol O-Methyltransferase; Cell Count; Cell Division; Cell Line; Cells, Cultured; Cytochrome P-450 Enzyme System; Cytosol; DNA; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Flavonoids; Fulvestrant; Humans; Inhibitory Concentration 50; Luteolin; Male; MAP Kinase Signaling System; Models, Biological; Muscle, Smooth, Vascular; Protein Binding; Quercetin; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Sex Factors; Time Factors; Tumor Cells, Cultured | 2000 |
Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism.
Topics: 2-Methoxyestradiol; Animals; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endothelins; Estradiol; Estrogen Receptor beta; Female; Fulvestrant; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Receptors, Estrogen; Swine; Time Factors | 2001 |
Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth.
Topics: 2-Methoxyestradiol; Cell Division; Cells, Cultured; Endothelium, Vascular; Estradiol; Fulvestrant; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Kidney Glomerulus; Nitric Oxide; Nitric Oxide Synthase; Progestins; Receptors, Estrogen | 2001 |
Increase of carcinogenic risk via enhancement of cyclooxygenase-2 expression and hydroxyestradiol accumulation in human lung cells as a result of interaction between BaP and 17-beta estradiol.
Topics: Air Pollutants; Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Bronchi; Carcinogens, Environmental; Cells, Cultured; Cyclooxygenase 2; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Dinoprostone; Drug Synergism; Enzyme Activation; Epithelial Cells; Estradiol; Estrogens, Catechol; Fulvestrant; Humans; In Vitro Techniques; Lung; Male; Membrane Proteins; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Estradiol; Up-Regulation | 2007 |
The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent manner.
Topics: 2-Methoxyestradiol; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Endometriosis; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans | 2016 |
2-hydroxyoestradiol and 2-methoxyoestradiol, two endogenous oestradiol metabolites, induce DNA fragmentation in Sertoli cells.
Topics: 2-Methoxyestradiol; Animals; Apoptosis; Caspase 3; Cell Line; Cell Survival; Child; DNA Fragmentation; Estradiol; Estrogen Receptor Antagonists; Fulvestrant; Humans; Male; Mice; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Sertoli Cells | 2016 |